HilleVax, Inc. Common Stock
HLVX
XNAS
•
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Cap
100M
Short interest (Aug 29)
0.7%
Net Short (Sep 16 ): 0.0%
Borrow Fee
2.40%
Available Shares
0
Price Chart
Company Overview
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
Company Info
Exchange:
NASDAQ
Industry:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CIK:
0001888012
Asset Type:
CS
Market Data
Market Cap:
$104,762,380
Employees:
14
Status:
Active
Short Interest
Current Borrow Fee
2.40%
Range: 2.40% -
2.40%
Available Shares
0
Range: 0 -
0
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.